Summit Financial’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $465K | Sell |
5,603
-706
| -11% | -$58.5K | 0.01% | 585 |
|
|
2025
Q1 | $512K | Sell |
6,309
-73
| -1% | -$5.92K | 0.01% | 507 |
|
|
2024
Q4 | $575K | Sell |
6,382
-248
| -4% | -$22.3K | 0.02% | 423 |
|
|
2024
Q3 | $655K | Sell |
6,630
-495
| -7% | -$48.9K | 0.03% | 327 |
|
|
2024
Q2 | $661K | Sell |
7,125
-2,027
| -22% | -$188K | 0.03% | 281 |
|
|
2024
Q1 | $868K | Buy |
9,152
+4,269
| +87% | +$405K | 0.05% | 202 |
|
|
2023
Q4 | $436K | Buy |
4,883
+1,101
| +29% | +$98.3K | 0.03% | 260 |
|
|
2023
Q3 | $276K | Hold |
3,782
| – | – | 0.02% | 294 |
|
|
2023
Q2 | $315K | Buy |
+3,782
| New | +$315K | 0.02% | 272 |
|